This site uses cookies

To give you the best possible experience, the GAM website uses cookies. You can read full information of our cookie use here. Your privacy is important to us and we encourage you to read our privacy policy here.

OK

Christophe Eggmann

Christophe Eggmann - Investment Director


Christophe Eggmann is an Investment Director responsible for GAM’s Healthcare Equity strategy.

Prior to joining GAM Investments in November 2010, he was Head of Equity Research at Julius Baer and equity analyst covering the global healthcare sector. Prior to that, he held various positions as a fund manager and equity analyst at Bank Hofmann, Rothschild Bank and Credit Suisse. Christophe Eggmann holds a Master's in Business Administration and Economics from the University of Neuchâtel and is a CFA Charterholder. He is based in Zurich.

Christophe Eggmann

My Insights

Weekly Manager Views 6 min read

Weekly Manager Views

17 January 2020

At GAM Investments’ Weekly Investment Meeting held on 15 January, the speakers were Christophe Eggmann, who commented on the pace of innovation in the healthcare sector, and Gianmarco Mondani, who shared his views on European equities from a non-directional perspective.

6 min read
Investment Opinions 5 min watch

Outlook 2020: What Themes Are You Looking Out For?

20 December 2019

We asked a number of our investment managers what themes they anticipate they are likely to focus on in 2020.

5 min watch
Investment Opinions 4 min watch

Outlook 2020: are we in a late cycle environment?

5 December 2019

We asked a number of our fund managers whether they believe we are now in a late cycle environment and what the implications are for their respective asset class.

4 min watch
Our Managers 8 min read

Fund Manager Portrait: Christophe Eggmann

28 August 2019

“While scientific development has proved a persistent theme in the healthcare industry for decades, it has not yet mirrored the bursts of disruptive innovation that have characterised the technology space… but that could be about to change abruptly.” This is the view of Christophe Eggmann, investment director, healthcare equities, who has been professionally involved in the sector for more than two decades.

8 min read